SLXP

Salix Pharmaceuticals and Valeant Pharmaceuticals have announced that they had entered into an agreement on their plan to merge based on a new price for Salix shares.
Stocks are still very close to all-time highs, and this bull market is now six years old. It turns out that some stocks made unusual moves last week.
While the selling that was reported this week was consistent with what we have seen so far in March, nothing indicates a mass exodus for shareholders at this point.
A new bid from Endo International has made the merger situation around Salix Pharmaceuticals much more complicated.
This Wednesday's top analyst upgrades, downgrades and initiations include Comcast, Groupon, HCA, J.P. Morgan, JetBlue, NetApp and Verifone.
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter rally in their shares.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Friday, October 3, 2014.
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Friday, September 12, 2014.
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical and...
Source: ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking for solid long ideas. In fact, firms like RBC use as...
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for...
24/7 Wall St. is tracking eleven key stocks on the move in the after-hours session. Most are of course on earnings, but this shows the move and a brief comment on the news flow of...
Source: Jon OggThe U.S. Food & Drug Administration has sent Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) a Complete Response Letter (CRL) regarding the...